IBRX
ImmunityBio, Inc.Company with tickers: IBRX
CIK
1326110
CUSIP
45256X103
Shares Outstanding
1,047,353,977
13F Activity (30d)
327 filings
311 filers
Price
$7.92
Market Cap
$8.30B
P/E Ratio
-20.84
EPS (Diluted)
$-0.38
52W High
$12.43
52W Low
$1.95
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $44,206,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Revenue (ASC 606) | $44,206,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $-69,791,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-632,782,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.62 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.62 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |